Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells

Ann Woolfrey, Jan Storek, Suzanne Bowyer, Robert Nelson, Michael Robertson, Carol Wallace

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Investigations of HCT for refractory JIA have employed high dose immunosuppressive drugs, such as CY and ATG with or without low dose TBI. Initial disease response has been observed in approximately two-thirds of patients; however, relapse occurs in about half of the responders. The current report describes a regimen with substantially increased dose of TBI, previously shown to be associated with high rate of disease response in adult patients with refractory MS and severe SSc. We report outcome of the lead patient in this pilot study, who remains in complete remission now, five yr after HCT. This regimen should be considered for patients with JIA refractory to medical therapies, including previous low intensity regimen HCT.

Original languageEnglish (US)
Pages (from-to)E65-E69
JournalPediatric Transplantation
Volume14
Issue number6
DOIs
StatePublished - Sep 1 2010

Fingerprint

Juvenile Arthritis
Whole-Body Irradiation
Immunosuppressive Agents
Recurrence
Peripheral Blood Stem Cells
Pharmaceutical Preparations
Therapeutics

Keywords

  • autologous peripheral blood stem cells
  • irradiation
  • juvenile idiopathic arthritis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells. / Woolfrey, Ann; Storek, Jan; Bowyer, Suzanne; Nelson, Robert; Robertson, Michael; Wallace, Carol.

In: Pediatric Transplantation, Vol. 14, No. 6, 01.09.2010, p. E65-E69.

Research output: Contribution to journalArticle

@article{b0a9a8d140d2404cbc39aec2dd536bd8,
title = "Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells",
abstract = "Investigations of HCT for refractory JIA have employed high dose immunosuppressive drugs, such as CY and ATG with or without low dose TBI. Initial disease response has been observed in approximately two-thirds of patients; however, relapse occurs in about half of the responders. The current report describes a regimen with substantially increased dose of TBI, previously shown to be associated with high rate of disease response in adult patients with refractory MS and severe SSc. We report outcome of the lead patient in this pilot study, who remains in complete remission now, five yr after HCT. This regimen should be considered for patients with JIA refractory to medical therapies, including previous low intensity regimen HCT.",
keywords = "autologous peripheral blood stem cells, irradiation, juvenile idiopathic arthritis",
author = "Ann Woolfrey and Jan Storek and Suzanne Bowyer and Robert Nelson and Michael Robertson and Carol Wallace",
year = "2010",
month = "9",
day = "1",
doi = "10.1111/j.1399-3046.2009.01129.x",
language = "English (US)",
volume = "14",
pages = "E65--E69",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Long-term response of juvenile idiopathic arthritis after conditioning with 8 Gy total body irradiation followed by autologous peripheral blood stem cells

AU - Woolfrey, Ann

AU - Storek, Jan

AU - Bowyer, Suzanne

AU - Nelson, Robert

AU - Robertson, Michael

AU - Wallace, Carol

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Investigations of HCT for refractory JIA have employed high dose immunosuppressive drugs, such as CY and ATG with or without low dose TBI. Initial disease response has been observed in approximately two-thirds of patients; however, relapse occurs in about half of the responders. The current report describes a regimen with substantially increased dose of TBI, previously shown to be associated with high rate of disease response in adult patients with refractory MS and severe SSc. We report outcome of the lead patient in this pilot study, who remains in complete remission now, five yr after HCT. This regimen should be considered for patients with JIA refractory to medical therapies, including previous low intensity regimen HCT.

AB - Investigations of HCT for refractory JIA have employed high dose immunosuppressive drugs, such as CY and ATG with or without low dose TBI. Initial disease response has been observed in approximately two-thirds of patients; however, relapse occurs in about half of the responders. The current report describes a regimen with substantially increased dose of TBI, previously shown to be associated with high rate of disease response in adult patients with refractory MS and severe SSc. We report outcome of the lead patient in this pilot study, who remains in complete remission now, five yr after HCT. This regimen should be considered for patients with JIA refractory to medical therapies, including previous low intensity regimen HCT.

KW - autologous peripheral blood stem cells

KW - irradiation

KW - juvenile idiopathic arthritis

UR - http://www.scopus.com/inward/record.url?scp=77955803951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955803951&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2009.01129.x

DO - 10.1111/j.1399-3046.2009.01129.x

M3 - Article

C2 - 19254270

AN - SCOPUS:77955803951

VL - 14

SP - E65-E69

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 6

ER -